fig5

Targeting senescence-mediated immune resistance for enhanced tumor immunotherapy

Figure 5. Reprogramming senescent cell function and the senescent TME to reverse immune evasion. (A) Senomorphic strategies suppress the deleterious effects of STCs by targeting key SASP-regulating pathways, including cGAS-STING, JAK-STAT, and NF-κB signaling, or by using neutralizing antibodies against specific SASP components. (B) Targeting senescent stromal and immune populations, including senescent CAFs and T cells, using senolytic or senomorphic approaches to remodel the senescent TME.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/